Abiopharma

🔍 SALKA SUSAN R (Director)

Company: Teladoc Health, Inc. (TDOC)

Report Date: 2026-03-30

Detailed Transactions and Holdings:

• Acquired 48,638 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 48,638.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
• F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.